GlassScriptPhysician profile
Reena R Nagar
NPI 1295197424
$1,592.86
in general payments reported to CMS, 2019-2025
25 companies · $699 in 2025
The $699 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.52 · 2022: $371 · 2023: $165 · 2024: $272 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $222.76 | 2024-2025 | |
| Si-Bone, INC. | $187.02 | 2022-2024 | |
| Neurelis, INC. | $155.39 | 2023-2025 | Valtoco |
| Medtronic, INC. | $146.03 | 2025 | Inceptiv |
| Lilly USA, LLC | $107.01 | 2022-2024 | Amyvid, Emgality |
| Teva Pharmaceuticals USA, INC. | $82.36 | 2022-2024 | Austedo Xr |
| Ucb, INC. | $81.94 | 2025 | Fintepla, Nayzilam |
| Boston Scientific Corporation | $57.80 | 2022-2025 | Intracept |
| Biogen, INC. | $55.87 | 2021-2025 | Vumerity |
| Lundbeck LLC | $50.48 | 2025 | Vyepti |
| Stryker Corporation | $49.09 | 2025 | Spinejack, Mild Device Kit |
| Argenx US, INC. | $48.00 | 2024-2025 | Vyvgart Hytrulo |
| Neurocrine Biosciences, INC. | $44.58 | 2022-2024 | Ingrezza |
| Merck Sharp & Dohme LLC | $40.21 | 2021-2024 | Bridion |
| Janssen Pharmaceuticals, INC | $36.59 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $33.24 | 2021 | |
| Alexion Pharmaceuticals, INC. | $29.40 | 2023 | Soliris |
| Averitas Pharma INC. | $24.04 | 2025 | Qutenza |
| Chiesi USA, INC. | $22.87 | 2022 | |
| Impel Pharmaceuticals LLC | $22.39 | 2025 | Trudhesa |
| Jazz Pharmaceuticals INC. | $22.05 | 2025 | |
| Grifols USA, LLC | $19.31 | 2022 | |
| Nevro Corp. | $18.64 | 2024 | Senza |
| Vertex Pharmaceuticals Incorporated | $17.93 | 2025 | |
| Protega Pharmaceutials INC | $17.86 | 2023 | Roxybond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reena Nagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.